Ellipse Technologies Overview
Ellipse Technologies General Information
Description
Developer of devices for treatment of spinal and orthopedic applications. The company is focused on the design, development and commercialization of non-invasively adjustable, remote-controlled implants for a broad spectrum of spinal and orthopedic deformity applications, orthopedic trauma and fracture management.
Want to dig into this profile?
We’ll help you find what you need
Learn more
Ellipse Technologies Valuation & Funding
| Deal Type |
Date |
Amount |
Raised to Date |
Post-Val |
Status |
Stage |
| 11. Merger/Acquisition |
19-Jan-2016 |
$410M |
000.00 |
00000 |
Completed |
Generating Revenue |
| 10. IPO |
05-Jan-2016 |
0000 |
|
|
Cancelled |
Generating Revenue |
| 9. Debt - General |
25-Jun-2015 |
|
000.00 |
|
Completed |
Generating Revenue |
| 8. Debt - General |
01-Apr-2014 |
00.00 |
000.00 |
|
Completed |
Generating Revenue |
| 7. Debt - General |
01-Jul-2013 |
00000 |
000.00 |
|
Completed |
Generating Revenue |
| 6. Later Stage VC (Series C) |
02-Aug-2011 |
0000 |
000.00 |
000.00 |
Completed |
Generating Revenue |
| 5. Debt - General |
26-Oct-2010 |
00.00 |
000.00 |
|
Completed |
Startup |
| 4. Debt - General |
08-Jan-2010 |
000 |
000.00 |
|
Completed |
Startup |
| 3. Early Stage VC (Series B) |
|
$3.72M |
$12.8M |
000.00 |
Completed |
Startup |
| 2. Early Stage VC (Series A) |
04-Dec-2006 |
$7.65M |
$9.1M |
000.00 |
Completed |
Startup |
Ellipse Technologies Cap Table
To view Ellipse Technologies‘s complete cap table, request access >>
| Stock |
# of Shares
Authorized |
Par Value |
Dividend Rate ($) |
Original
Issue Price |
Liquidation |
Liquidation
Pref. Multiple |
Conversion Price |
% Owned |
| Series C |
00,000,000 |
00.000000 |
00 |
00.00 |
00.00 |
00 |
00.00 |
00.000 |
| Series B1 |
00,000 |
00.000000 |
|
00.0 |
00.0 |
00 |
00.0 |
0.000 |
| Series B |
00,000,000 |
00.000000 |
00 |
00.0 |
00.00 |
00 |
00.0 |
00.000 |
| Series A2 |
3,093,808 |
$0.001000 |
|
$0.6 |
$0.6 |
1x |
$0.6 |
3.84% |
| Series A1 |
9,448,817 |
$0.001000 |
$0.06 |
$0.6 |
$0.9 |
1x |
$0.6 |
11.84% |
Ellipse Technologies Competitors (31)
| Company Name |
Financing Status |
Location |
Employees |
Total Raised |
Last Financing Date/Type |
Last Financing
Amount |
| Vexim |
Formerly VC-backed |
Balma, France |
00 |
000.00 |
00000000000 |
|
| 00000 0000 |
Venture Capital-Backed |
Shelton, CT |
000 |
00000 |
0000000000 0 |
00000 |
| 00000000 0000000 |
Venture Capital-Backed |
Sunnyvale, CA |
00 |
000.00 |
0000 |
000.00 |
| 0000000 0000000000 |
Corporation |
Princeton, NJ |
0000 |
00000 |
000000 - 000 |
00000 |
| 00000 0000000 |
Corporate Backed or Acquired |
Belgrade, MT |
000 |
000.00 |
000000 - 000 |
000.00 |
Ellipse Technologies Executive Team (12)
| Name |
Title |
Board Seat |
Contact Info |
| Jeff Rydin |
Chief Sales Officer |
|
|
| Michael Moeller |
Senior Vice President, Research & Development and Operations |
|
|
| Todd Koning |
Vice President, Finance |
|
|
| Stuart Gomm |
Vice President, Global Sales & Marketing, Spine/Orthopedics |
|
|
| Neil Beals |
Vice President, Marketing |
|
|
3 Former Executives